| Year |
Citation |
Score |
| 2024 |
Yin L, Hu X, Pei G, Tang M, Zhou Y, Zhang H, Huang M, Li S, Zhang J, Citu C, Zhao Z, Debeb BG, Feng X, Chen J. Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy. Life Science Alliance. 7. PMID 38316463 DOI: 10.26508/lsa.202302353 |
0.355 |
|
| 2021 |
Schlee Villodre E, Hu X, Eckhardt BL, Larson R, Huo L, Yoon EC, Gong Y, Song J, Liu S, Ueno NT, Krishnamurthy S, Pusch S, Tripathy D, Woodward WA, Debeb BG. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. Journal of the National Cancer Institute. PMID 34893874 DOI: 10.1093/jnci/djab222 |
0.434 |
|
| 2021 |
Santiago-Sánchez GS, Noriega-Rivera R, Hernández-O'Farrill E, Valiyeva F, Quiñones-Diaz B, Villodre ES, Debeb BG, Rosado-Albacarys A, Vivas-Mejía PE. Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors. International Journal of Molecular Sciences. 22. PMID 34445288 DOI: 10.3390/ijms22168581 |
0.468 |
|
| 2021 |
Villodre ES, Hu X, Larson R, Finetti P, Gomez K, Balema W, Stecklein SR, Santiago-Sanchez G, Krishnamurthy S, Song J, Su X, Ueno NT, Tripathy D, Van Laere S, Bertucci F, ... ... Debeb BG, et al. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Molecular Oncology. PMID 34342930 DOI: 10.1002/1878-0261.13074 |
0.526 |
|
| 2021 |
Balema W, Liu D, Shen Y, El-Zein R, Debeb BG, Kai M, Overmoyer B, Miller KD, Le-Petross HT, Ueno NT, Woodward WA. Inflammatory breast cancer appearance at presentation is associated with overall survival. Cancer Medicine. PMID 34327874 DOI: 10.1002/cam4.4170 |
0.366 |
|
| 2021 |
Smith DL, Debeb BG, Diagaradjane P, Larson R, Kumar S, Ning J, Lacerda L, Li L, Woodward WA. Prophylactic cranial irradiation reduces the incidence of brain metastasis in a mouse model of metastatic, HER2-positive breast cancer. Genes & Cancer. 12: 28-38. PMID 33884104 DOI: 10.18632/genesandcancer.212 |
0.335 |
|
| 2021 |
Hu X, Villodre ES, Woodward WA, Debeb BG. Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells. Journal of Visualized Experiments : Jove. PMID 33616115 DOI: 10.3791/62249 |
0.385 |
|
| 2021 |
Hu X, Villodre ES, Larson R, Rahal OM, Wang X, Gong Y, Song J, Krishnamurthy S, Ueno NT, Tripathy D, Woodward WA, Debeb BG. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Communications Biology. 4: 72. PMID 33452400 DOI: 10.1038/s42003-020-01590-0 |
0.459 |
|
| 2020 |
Villodre ES, Gong Y, Hu X, Huo L, Yoon EC, Ueno NT, Woodward WA, Tripathy D, Song J, Debeb BG. NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer. Cancers. 12. PMID 33321961 DOI: 10.3390/cancers12123711 |
0.377 |
|
| 2020 |
Gagliardi M, Pitner MK, Park J, Xie X, Saso H, Larson RA, Sammons RM, Chen H, Wei C, Masuda H, Chauhan G, Kondo K, Tripathy D, Ueno NT, Dalby KN, ... Debeb BG, et al. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer. Scientific Reports. 10: 8537. PMID 32444778 DOI: 10.1038/S41598-020-65250-3 |
0.535 |
|
| 2020 |
Villodre ES, Hu X, Larson R, Eckhardt BL, Gong Y, Huo L, Song J, Krishnamurthy S, Ibrahim N, Ueno NT, Tripathy D, Woodward WA, Debeb BG. Abstract P3-01-10: Ndrg1-egfr axis in inflammatory breast cancer tumorigenesis and brain metastasis Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P3-01-10 |
0.46 |
|
| 2020 |
Hu X, Villodre ES, Larson R, Rahal OM, Wang X, Krishnamurthy S, Tripathy D, Ueno NT, Woodward WA, Debeb BG. Abstract P3-01-06: Decorin-mediated suppression of tumorigenesis and skin invasion in inflammatory breast cancer via inhibition of the E-cadherin/EGFR axis Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-01-06 |
0.547 |
|
| 2020 |
Rahal O, Stecklein S, Larson R, Van Wyhe R, Villodre E, Debeb B, Woodward W. Protein Kinase C Zeta (PKCζ) Knockdown Increases Radiation Sensitivity and Reduces Brain Colonization of HER2-Neu Overexpressing Inflammatory Breast Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 108: S24. DOI: 10.1016/j.ijrobp.2020.07.2112 |
0.389 |
|
| 2019 |
Bertucci F, Rypens C, Finetti P, Guille A, Adelaïde J, Monneur A, Carbuccia N, Garnier S, Dirix P, Gonçalves A, Vermeulen P, Debeb BG, Wang X, Dirix L, Ueno NT, et al. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. Molecular Oncology. PMID 31854063 DOI: 10.1002/1878-0261.12621 |
0.401 |
|
| 2019 |
Villodre E, Larson R, Hu X, Stecklein S, Gomez K, Finetti P, Krishnamurthy S, Ivan C, Su X, Ueno N, Laere SV, Bertucci F, Tripathy D, Vivas-Mejía P, Woodward WA, ... Debeb B, et al. Abstract P2-01-03: Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-01-03 |
0.536 |
|
| 2018 |
Reddy JP, Atkinson RL, Larson R, Burks JK, Smith D, Debeb BG, Ruffell B, Creighton CJ, Bambhroliya A, Reuben JM, Van Laere SJ, Krishnamurthy S, Symmans WF, Brewster AM, Woodward WA. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast Cancer Research and Treatment. PMID 29858753 DOI: 10.1007/S10549-018-4835-6 |
0.561 |
|
| 2018 |
Ding Q, Wang Y, Zuo Z, Gong Y, Krishnamurthy S, Li CW, Lai YJ, Wei W, Wang J, Manyam GC, Diao L, Zhang X, Lin F, Symmans WF, Sun L, ... ... Debeb BG, et al. Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer. Human Pathology. PMID 29689244 DOI: 10.1016/J.Humpath.2018.04.002 |
0.506 |
|
| 2018 |
Bambhroliya A, Van Wyhe RD, Kumar S, Debeb BG, Reddy JP, Van Laere S, El-Zein R, Rao A, Woodward WA. Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer. Plos One. 13: e0192689. PMID 29617367 DOI: 10.1371/Journal.Pone.0192689 |
0.464 |
|
| 2018 |
Uemura MI, French JT, Hess KR, Liu D, Raghav K, Hortobagyi GN, Arun BK, Valero V, Ueno NT, Alvarez RH, Woodward WA, Debeb BG, Moulder SL, Lim B, Tripathy D, et al. Development of CNS metastases and survival in patients with inflammatory breast cancer. Cancer. PMID 29579338 DOI: 10.1002/cncr.31336 |
0.392 |
|
| 2018 |
Santiago-Sanchez GS, Valiyeva F, Debeb B, Mejia PE. Abstract 3969: Lipocalin-2-targeted small interference RNA for inflammatory breast cancer treatment Cancer Research. 78: 3969-3969. DOI: 10.1158/1538-7445.Am2018-3969 |
0.549 |
|
| 2018 |
Stecklein SR, Wolfe AR, Debeb BG, Larson RA, Woodward WA. Abstract 2397: Intracellular cholesterol regulates the DNA damage response in inflammatory breast cancer Cancer Research. 78: 2397-2397. DOI: 10.1158/1538-7445.Am2018-2397 |
0.395 |
|
| 2017 |
Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, et al. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10 Anniversary Conference. Journal of Cancer. 8: 3607-3614. PMID 29667990 DOI: 10.7150/Jca.21200 |
0.38 |
|
| 2017 |
Stecklein SR, Reddy JP, Wolfe AR, Lopez MS, Fouad TM, Debeb BG, Ueno NT, Brewster AM, Woodward WA. Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival. Journal of Cancer. 8: 1726-1732. PMID 28819368 DOI: 10.7150/Jca.20095 |
0.484 |
|
| 2017 |
Jolly MK, Boareto M, Debeb BG, Aceto N, Farach-Carson MC, Woodward WA, Levine H. Inflammatory breast cancer: a model for investigating cluster-based dissemination. Npj Breast Cancer. 3: 21. PMID 28649661 DOI: 10.1038/s41523-017-0023-9 |
0.36 |
|
| 2017 |
Reddy J, Atkinson R, Larson R, Burks J, Smith D, Debeb B, Ruffell B, Creighton C, Reuben J, Krishnamurthy S, Symmans W, Brewster A, Laere SV. Abstract P4-03-14: Stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P4-03-14 |
0.536 |
|
| 2017 |
Caceres S, Peña L, Lacerda L, Illera MJ, Larson RA, Gao H, Debeb BG, Woodward WA, Reuben JM, Illera JC. Characterization of Non-Adherent Cells from IPC-366, A Canine Inflammatory Mammary Cancer Cell Line Journal of Comparative Pathology. 156: 120. DOI: 10.1016/J.Jcpa.2016.11.201 |
0.489 |
|
| 2016 |
Wolfe AR, Trenton NJ, Debeb BG, Larson R, Ruffell B, Chu K, Hittelman W, Diehl M, Reuben JM, Ueno NT, Woodward WA. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models. Oncotarget. PMID 27756885 DOI: 10.18632/Oncotarget.12694 |
0.48 |
|
| 2016 |
Smith DL, Debeb BG, Thames HD, Woodward WA. Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response. International Journal of Radiation Oncology, Biology, Physics. 96: 179-87. PMID 27511855 DOI: 10.1016/J.Ijrobp.2016.04.014 |
0.427 |
|
| 2016 |
Caceres S, Peña L, Lacerda L, Illera MJ, de Andres PJ, Larson RA, Gao H, Debeb BG, Woodward WA, Reuben JM, Illera JC. Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer. Veterinary and Comparative Oncology. PMID 27146723 DOI: 10.1111/Vco.12238 |
0.555 |
|
| 2016 |
Debeb BG, Lacerda L, Larson R, Wolfe AR, Krishnamurthy S, Reuben JM, Ueno NT, Gilcrease M, Woodward WA. Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism. Oncotarget. PMID 27078845 DOI: 10.18632/Oncotarget.8631 |
0.512 |
|
| 2016 |
Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, et al. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. Journal of the National Cancer Institute. 108. PMID 27075851 DOI: 10.1093/Jnci/Djw026 |
0.385 |
|
| 2016 |
Wolfe AR, Bambhroliya A, Reddy JP, Debeb BG, Huo L, Larson R, Li L, Ueno NT, Woodward WA. MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 27055396 DOI: 10.1016/J.Ijrobp.2016.01.025 |
0.449 |
|
| 2016 |
Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, ... ... Debeb BG, et al. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26916073 DOI: 10.1038/Modpathol.2016.38 |
0.532 |
|
| 2016 |
Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Larson R, Chu K, Huo L, Smith D, Li L, Ivan C, Allen P, Zhang X, Calin G, Krishanmurthy S, Buchholz T, et al. Abstract A55: A novel mediator of brain metastasis from breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-A55 |
0.426 |
|
| 2016 |
Pitner MK, Saso H, Larson R, Sammons RM, Chen H, Wei C, Chauhan G, Kondo K, Ueno NT, Dalby K, Debeb BG, Bartholomeusz C. Abstract 1624: Silencing of ERK2 reverses EMT and suppresses the CSC phenotype, inhibiting lung metastasis in triple-negative breast cancer Cancer Research. 76: 1624-1624. DOI: 10.1158/1538-7445.Am2016-1624 |
0.551 |
|
| 2015 |
Wolfe AR, Debeb BG, Lacerda L, Larson R, Bambhroliya A, Huang X, Bertucci F, Finetti P, Birnbaum D, Van Laere S, Diagaradjan P, Ruffell B, Trenton NJ, Chu K, Hittelman W, et al. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a. Breast Cancer Research and Treatment. PMID 26590814 DOI: 10.1007/S10549-015-3645-3 |
0.58 |
|
| 2015 |
Reddy JP, Dawood S, Mitchell M, Debeb BG, Bloom E, Gonzalez-Angulo AM, Sulman EP, Buchholz TA, Woodward WA. Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26482599 DOI: 10.1016/J.Radonc.2015.10.009 |
0.413 |
|
| 2015 |
Cohen EN, Gao H, Anfossi S, Mego M, Reddy NG, Debeb B, Giordano A, Tin S, Wu Q, Garza RJ, Cristofanilli M, Mani SA, Croix DA, Ueno NT, Woodward WA, et al. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells. Plos One. 10: e0132710. PMID 26207636 DOI: 10.1371/Journal.Pone.0132710 |
0.553 |
|
| 2015 |
Smith D, Debeb B, Larson R, Diagaradjane P, Woodward W. WE-EF-BRA-10: Prophylactic Cranial Irradiation Reduces the Incidence of Brain Metastasis in a Mouse Model of Metastatic Breast Cancerr. Medical Physics. 42: 3676. PMID 26129288 DOI: 10.1118/1.4925989 |
0.442 |
|
| 2015 |
Smith D, Debeb B, Woodward W. SU-E-T-664: Radiobiological Modeling of Prophylactic Cranial Irradiation in Mice. Medical Physics. 42: 3489. PMID 26128327 DOI: 10.1118/1.4925027 |
0.336 |
|
| 2015 |
Lacerda L, Debeb BG, Smith D, Larson R, Solley T, Xu W, Krishnamurthy S, Gong Y, Levy LB, Buchholz T, Ueno NT, Klopp A, Woodward WA. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast Cancer Research : Bcr. 17: 42. PMID 25887413 DOI: 10.1186/S13058-015-0549-4 |
0.55 |
|
| 2015 |
Wolfe AR, Atkinson RL, Reddy JP, Debeb BG, Larson R, Li L, Masuda H, Brewer T, Atkinson BJ, Brewster A, Ueno NT, Woodward WA. High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer. International Journal of Radiation Oncology, Biology, Physics. 91: 1072-80. PMID 25832697 DOI: 10.1016/J.Ijrobp.2014.12.039 |
0.437 |
|
| 2015 |
Debeb BG, Smith DL, Li L, Larson R, Xu W, Woodward WA. Differential effect of phosphorylation-defective survivin on radiation response in estrogen receptor-positive and -negative breast cancer. Plos One. 10: e0120719. PMID 25763854 DOI: 10.1371/Journal.Pone.0120719 |
0.502 |
|
| 2015 |
French JT, Hess KR, Liu DD, Raghav KPS, Hortobagyi GN, Arun B, Valero V, Ueno NT, Alvarez RH, Woodward WA, Debeb BG, Moulder SL, Lim B, Tripathy D, Ibrahim NK. Development of CNS metastasis and subsequent survival in patients with inflammatory breast cancer. Journal of Clinical Oncology. 33: 1586-1586. DOI: 10.1200/Jco.2015.33.15_Suppl.1586 |
0.429 |
|
| 2015 |
Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Zhang XH, et al. Abstract P6-16-01: The microRNA miR-141 is a key regulator of brain metastasis from breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-16-01 |
0.435 |
|
| 2015 |
Caceres S, Peña L, Cerda LCAdl, Illera MJ, Larson R, Gao H, Debeb BG, Woodward WA, Reuben JM, Illera JC. Abstract P5-07-04: Characterization of a new canine inflammatory mammary cancer (IMC) cell line (IPC-366) Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P5-07-04 |
0.539 |
|
| 2015 |
Wolfe AR, Atkinson R, Debeb BG, Zhang Y, Ruffel B, Reuben JM, Ueno NT, Woodward WA. Abstract P4-04-09: Mesenchymal stem cells and macrophage interactions promote inflammatory breast cancer cell invasion and self renewal Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-04-09 |
0.529 |
|
| 2015 |
Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Huo L, Wei C, Larson R, Wolfe A, Xu W, Li L, Smith D, Ivan C, Allen P, Krishnamurthy S, et al. Abstract 3087: MicroRNA 141: A novel regulator of brain metastasis from breast cancer Cancer Research. 75: 3087-3087. DOI: 10.1158/1538-7445.Am2015-3087 |
0.427 |
|
| 2015 |
Stecklein SR, Reddy J, Wolfe A, Lopez MS, Fouad TM, Debeb BG, Brewster AM, Ueno NT, Woodward WA. Lack of Breastfeeding History in Parous Women With Inflammatory Breast Cancer Predicts Locoregional Recurrence and Distant Metastasis International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.563 |
0.385 |
|
| 2015 |
Wolfe A, Bambhroliya A, Reddy J, Debeb BG, Woodward WA. MiR-33a Regulates Radiation Sensitivity to High Density Lipoprotein in Breast Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1898 |
0.398 |
|
| 2014 |
Smith D, Debeb B, Woodward W. SU-E-T-320: The Effect of Survivin Perturbation On the Radiation Response of Breast Cancer Cell Lines. Medical Physics. 41: 298. PMID 28036960 DOI: 10.1118/1.4888653 |
0.51 |
|
| 2014 |
Zhang P, Wang L, Rodriguez-Aguayo C, Yuan Y, Debeb BG, Chen D, Sun Y, You MJ, Liu Y, Dean DC, Woodward WA, Liang H, Yang X, Lopez-Berestein G, Sood AK, et al. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nature Communications. 5: 5671. PMID 25476932 DOI: 10.1038/Ncomms6671 |
0.372 |
|
| 2014 |
Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, Yuan J, Wang M, Chen D, Sun Y, Woodward WA, Liu Y, Dean DC, Liang H, Hu Y, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nature Cell Biology. 16: 864-75. PMID 25086746 DOI: 10.1038/Ncb3013 |
0.444 |
|
| 2014 |
Debeb BG, Gong Y, Atkinson RL, Sneige N, Huo L, Gonzalez-Angulo AM, Hung MC, Valero V, Ueno NT, Woodward WA. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. Journal of Experimental & Clinical Cancer Research : Cr. 33: 58. PMID 25051981 DOI: 10.1186/S13046-014-0058-9 |
0.544 |
|
| 2014 |
Lacerda L, Reddy JP, Liu D, Larson R, Li L, Masuda H, Brewer T, Debeb BG, Xu W, Hortobágyi GN, Buchholz TA, Ueno NT, Woodward WA. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Translational Medicine. 3: 849-56. PMID 24833589 DOI: 10.5966/Sctm.2013-0204 |
0.582 |
|
| 2014 |
Anfossi S, Giordano A, Gao H, Cohen EN, Tin S, Wu Q, Garza RJ, Debeb BG, Alvarez RH, Valero V, Hortobagyi GN, Calin GA, Ueno NT, Woodward WA, Reuben JM. High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer. Plos One. 9: e83113. PMID 24416156 DOI: 10.1371/Journal.Pone.0083113 |
0.463 |
|
| 2014 |
Debeb BG, Woodward WA. ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome Breast Diseases. 25: 47-48. DOI: 10.1016/J.Breastdis.2014.01.027 |
0.429 |
|
| 2013 |
Xu W, Lacerda L, Debeb BG, Atkinson RL, Solley TN, Li L, Orton D, McMurray JS, Hang BI, Lee E, Klopp AH, Ueno NT, Reuben JM, Krishnamurthy S, Woodward WA. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. Plos One. 8: e71508. PMID 24013655 DOI: 10.1371/Journal.Pone.0071508 |
0.577 |
|
| 2013 |
Duong MT, Akli S, Macalou S, Biernacka A, Debeb BG, Yi M, Hunt KK, Keyomarsi K. Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells. Cancer Research. 73: 5556-68. PMID 23955388 DOI: 10.1158/0008-5472.Can-13-0013 |
0.47 |
|
| 2013 |
Lacerda L, Smith D, Debeb B, Solley T, Larson R, Xu W, Krishnamurthy S, Ueno N, Klopp A, Woodward W. Abstract B69: Mesenchymal stem cells promote tumor-skin involvement in inflammatory breast cancer models Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B69 |
0.484 |
|
| 2013 |
Debeb BG, Lacerda L, Larson R, Li L, Xu W, Huo L, Wei C, Krishnamurthy S, Reuben J, Ueno N, Buchholz T, Woodward WA, C. Abstract 3051: The miR-200 family as a potential therapeutic target in inflammatory breast cancer. Cancer Research. 73: 3051-3051. DOI: 10.1158/1538-7445.Am2013-3051 |
0.412 |
|
| 2013 |
Wolfe AR, Lacerda L, Larson R, Debeb BG, Xu W, Ueno NT, Woodward WA. Abstract 1600: Simvastatin targets breast cancer stem-like cells by inhibiting intracellular signaling pathways leading to radiosensitization of inflammatory breast cancer cells. Cancer Research. 73: 1600-1600. DOI: 10.1158/1538-7445.Am2013-1600 |
0.625 |
|
| 2013 |
Anfossi S, Burks J, Giordano A, Cohen E, Gao H, Debeb B, Woodward W, Ueno N, Ricardo A, Hortobagyi G, Valero V, Reuben J. Abstract P6-12-12: MiR-19a released by the triple negative inflammatory breast cancer SUM149 cells can be taken up by dendritic cells and induce increased synthesis of the proinflammatory cytokines IL-6 and TNF-a Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P6-12-12 |
0.386 |
|
| 2013 |
Lacerda L, Garza R, Cohen E, Atkinson R, Solley T, Li L, Debeb B, Xu W, Reuben J, Klopp A, Woodward W. Abstract P1-06-05: Expansion of tumor initiating cells is mediated by tumor microenvironment in breast cancer metastasis Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-06-05 |
0.522 |
|
| 2012 |
Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling. Stem Cells (Dayton, Ohio). 30: 2366-77. PMID 22961641 DOI: 10.1002/Stem.1219 |
0.576 |
|
| 2012 |
Debeb BG, Cohen EN, Boley K, Freiter EM, Li L, Robertson FM, Reuben JM, Cristofanilli M, Buchholz TA, Woodward WA. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Research and Treatment. 134: 495-510. PMID 22547109 DOI: 10.1007/S10549-012-2075-8 |
0.57 |
|
| 2012 |
Klopp AH, Zhang Y, Solley T, Amaya-Manzanares F, Marini F, Andreeff M, Debeb B, Woodward W, Schmandt R, Broaddus R, Lu K, Kolonin MG. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 771-82. PMID 22167410 DOI: 10.1158/1078-0432.Ccr-11-1916 |
0.333 |
|
| 2012 |
Lacerda LCAd, Klopp AH, Garza RJ, Cohen EN, Solley TN, Li L, Debeb BG, Xu W, Reuben JM, Woodward WA. Abstract 5210: Impact of tumor microenvironment on expansion of tumor initiating cells in breast cancer metastasis Cancer Research. 72: 5210-5210. DOI: 10.1158/1538-7445.Am2012-5210 |
0.525 |
|
| 2012 |
Debeb BG, Xu W, Lacerda L, Li L, Caimiao W, Reuben JM, Ueno NT, Buchholz TA, Woodward WA. Abstract 5044: Radiation modulates expression of microRNAs in breast cancer cell lines grown under adherent and stem cell promoting culture conditions Cancer Research. 72: 5044-5044. DOI: 10.1158/1538-7445.Am2012-5044 |
0.577 |
|
| 2012 |
Lacerda L, Reddy J, Liu D, Larson R, Masuda H, Brewer T, Debeb B, Xu W, Hortobagyi G, Buchholz T, Ueno N, Woodward W. Abstract PD03-06: Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with post-mastectomy radiation Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pd03-06 |
0.575 |
|
| 2012 |
Xu W, Debeb B, Smith D, Li J, Ueno N, Alvarez dLL, Larson R, Schwba L, Seagroves T, Woodward W. Abstract P5-03-10: HIF-1alpha knockout radiosensitizes select Inflammatory Breast Cancer cells through reduction of stem-like cancer cells Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P5-03-10 |
0.494 |
|
| 2012 |
Debeb B, Larson R, Lacerda L, Xu W, Smith D, Ueno N, Reuben J, Gilcrease M, Krishnamurthy S, Buchholz T, Woodward W. Abstract P5-03-05: Histone deacetylase (HDAC)-inhibitor mediated reprogramming drives cancer cells to the pentose phosphate metabolic pathway Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P5-03-05 |
0.527 |
|
| 2012 |
Woodward W, Huo L, Li J, Sneige N, Gonzalez-Angulo A, Debeb B, Chang C, Hung M, Valero V, Ueno N. EZH2 Expression Correlates With Locoregional Recurrence After Radiation in Inflammatory Breast Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S714. DOI: 10.1016/J.IJROBP.2012.07.1911 |
0.381 |
|
| 2011 |
Xu W, Debeb BG, Lacerda L, Li J, Woodward WA. Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro. Cancers. 3: 2274-85. PMID 24212809 DOI: 10.3390/Cancers3022274 |
0.556 |
|
| 2011 |
Debeb BG, Lacerda L, Xu W, Robertson F, Ueno NT, Lucci A, Reuben JM, Buchholz TA, Woodward WA. Abstract 3340: Expansion of human breast cancer stem /progenitor cell subpopulation through histone deacetylase inhibitors Cancer Research. 71: 3340-3340. DOI: 10.1158/1538-7445.Am2011-3340 |
0.557 |
|
| 2011 |
Lacerda L, Solley T, Debeb B, Xu W, Krisnamurthy S, Ueno N, Reuben J, Klopp A, Woodward W. P2-01-13: Impact of Erlotinib on MSC-Mediated TIC Expansion and EMT. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-01-13 |
0.615 |
|
| 2011 |
Debeb B, Larson R, Xu W, Lacerda L, Reuben J, Buchholz T, Ueno N, Woodward W. P1-04-03: The Effect of Survivin Downregulation on Radiosensitization of Breast Cancer Cell Lines Grown under Adherent and Stem Cell Promoting Culture Conditions. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-04-03 |
0.536 |
|
| 2011 |
Xu W, Debeb B, Lacerda Ad, Li L, Larson R, Reuben J, Ueno N, Woodward W. P1-04-01: The Mechanism of Anti-Breast Cancer TICs Effect of Pyrvinium Pamoate Is through WNT/beta-Catenin Signaling. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-04-01 |
0.458 |
|
| 2010 |
Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, Li L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, et al. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. Plos One. 5: e12180. PMID 20808935 DOI: 10.1371/Journal.Pone.0012180 |
0.548 |
|
| 2010 |
Robertson FM, Ogasawara MA, Ye Z, Chu K, Pickei R, Debeb BG, Woodward WA, Hittelman WN, Cristofanilli M, Barsky SH. Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype. Journal of Biomolecular Screening. 15: 820-9. PMID 20639504 DOI: 10.1177/1087057110376541 |
0.478 |
|
| 2010 |
Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT, Robertson F, Xu W, Lacerda L, Buchholz TA, Cristofanilli M, et al. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Molecular Cancer. 9: 180. PMID 20615238 DOI: 10.1186/1476-4598-9-180 |
0.532 |
|
| 2010 |
Woodward WA, Debeb BG, Xu W, Buchholz TA. Overcoming radiation resistance in inflammatory breast cancer. Cancer. 116: 2840-5. PMID 20503417 DOI: 10.1002/Cncr.25173 |
0.553 |
|
| 2010 |
Xu W, Debeb BG, Lacerda L, Woodward WA. Potential targets for improving radiosensitivity of breast tumor-initiating cells. Anti-Cancer Agents in Medicinal Chemistry. 10: 152-6. PMID 20184537 DOI: 10.2174/187152010790909362 |
0.485 |
|
| 2010 |
Debeb BG, Xu W, Mok H, Li L, Robertson F, Ueno NT, Reuben J, Lucci A, Cristofanilli M, Woodward WA. Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions. International Journal of Radiation Oncology, Biology, Physics. 76: 889-95. PMID 20159363 DOI: 10.1016/J.Ijrobp.2009.09.052 |
0.533 |
|
| 2010 |
Klopp AH, Lacerda L, Gupta A, Debeb B, Marini F, Andreeff M, Woodward WA. Abstract 560: Mesenchymal stem cells promote mammosphere formation in normal and malignant breast cells Cancer Research. 70: 560-560. DOI: 10.1158/1538-7445.Am10-560 |
0.609 |
|
| 2010 |
Lacerda L, Gupta A, Debeb B, Xu W, Meyn R, Marini F, Andreeff M, Woodward W, Klopp A. Abstract PD02-07: Impact of Mesenchymal Stem Cells on Radiation Therapy Response Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Pd02-07 |
0.522 |
|
| 2010 |
Xu W, Debeb B, Lacerda LAd, Woodward W. Abstract P6-14-11: ß-Catenin Inhibitor SST-024 Can Sensitize Breast Cancer Tumor Initiation Cells (TICs) to Ionized Radiotherapy Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P6-14-11 |
0.563 |
|
| 2010 |
Debeb B, Xu W, Lacerda L, Hortobagyi G, Robertson F, Ueno N, Lucci A, Reuben J, Buchholz T, Woodward W. Abstract P4-04-05: Histone Deacetylase Inhibitors Increase Markers of the Dedifferentiated Cancer Stem Cell Phenotype in Human Breast Cancer Cells Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P4-04-05 |
0.566 |
|
| 2009 |
Debeb BG, Galat V, Epple-Farmer J, Iannaccone S, Woodward WA, Bader M, Iannaccone P, Binas B. Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines. Plos One. 4: e7216. PMID 19784378 DOI: 10.1371/Journal.Pone.0007216 |
0.661 |
|
| 2009 |
Epple-Farmer J, Debeb BG, Smithies O, Binas B. Gender-dependent survival of allogeneic trophoblast stem cells in liver. Cell Transplantation. 18: 769-76. PMID 19523327 DOI: 10.3727/096368909X470856 |
0.64 |
|
| 2009 |
Galat V, Binas B, Iannaccone S, Postovit LM, Debeb BG, Iannaccone P. Developmental potential of rat extraembryonic stem cells. Stem Cells and Development. 18: 1309-18. PMID 19480599 DOI: 10.1089/Scd.2009.0115 |
0.674 |
|
| 2009 |
Debeb BG, Xu W, Woodward WA. Radiation resistance of breast cancer stem cells: understanding the clinical framework. Journal of Mammary Gland Biology and Neoplasia. 14: 11-7. PMID 19252973 DOI: 10.1007/S10911-009-9114-Z |
0.542 |
|
| 2009 |
Hall C, Debeb B, Xu W, Ueno N, Reuben J, Robertson F, Lucci A, Buchholz T, Hortobagyi G, Cristofanilli M, Woodward W. Novel inflammatory breast cancer cell line, MDA-IBC-1 expresses and secretes WISP3, a putative tumor suppressor in inflammatory breast cancer. Cancer Research. 69: 1051. DOI: 10.1158/0008-5472.Sabcs-1051 |
0.526 |
|
| 2009 |
Debeb B, Hall C, Xu W, Ueno N, Reuben J, Robertson F, Lucci A, Buchholz T, Hortobagyi G, Cristofanilli M, Woodward W. Populations of cells exhibiting epithelial-mesenchymal transition (EMT) or stem cell characteristics can be propagated from a single inflammatory breast cancer (IBC) cell line based on culture conditions. Cancer Research. 69: 103. DOI: 10.1158/0008-5472.Sabcs-103 |
0.434 |
|
| Show low-probability matches. |